The startup develops bronchoscopic robotic technology that enhances lung cancer biopsy and therapeutic procedures through real-time imaging and needle-in-tissue verification. This technology improves diagnostic accuracy and treatment efficiency, enabling medical researchers to refine their approaches to patient care.
Funding
$430K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current bronchoscopy methods for lung cancer diagnosis and treatment face challenges in precise navigation and real-time confirmation of needle placement within lung tissue. This can lead to inaccurate biopsies, incomplete tumor ablation, and increased risk of complications.
Solution
The startup offers a bronchoscopic robotic system designed to improve the accuracy and efficacy of lung cancer procedures. The system integrates real-time imaging modalities with a robotic needle guide, allowing physicians to visualize and precisely target suspicious lesions within the lung. Needle-in-tissue verification technology confirms accurate placement before biopsy or therapy delivery. This enhanced precision aims to improve diagnostic yield, enable more complete tumor treatment, and reduce the potential for adverse events.
Target Audience
The primary target audience includes pulmonologists, thoracic surgeons, and interventional radiologists specializing in lung cancer diagnosis and treatment, as well as hospitals and cancer centers.
Features
- Robotic-assisted navigation for precise bronchoscopic access to peripheral lung nodules
- Real-time imaging integration (e.g., electromagnetic navigation, cone-beam CT) for enhanced visualization
- Needle-in-tissue verification sensors to confirm accurate placement before sampling or ablation
- Articulating robotic arm with multiple degrees of freedom for maneuverability within the bronchial tree
- Integrated software platform for procedure planning, image guidance, and data management
- Compatibility with standard bronchoscopes and biopsy needles